Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW -- Ignore unavailable to you. Want to Upgrade?

To: KiddStock who wrote (426)	10/5/1998 9:52:00 PM
From: T-Lo Greens	Respond to of 857

As you can see today HEB closed strong, but on relatively low volume. Let's see what tomorrow brings...and how well they present at the conference.

To: KiddStock who wrote (426)	10/6/1998 12:24:00 AM
From: Cavalry	Respond to of 857

here is big difference other drug companies asenio attacked were different. dont know companies name some test which avoids pricking babies foot i believe. who will fight for that the company the babies mothers, the doctors, sorry, abte had shakey books, ampligen is so many peoples only hope. you should see the desperation of these people on the net seeking some cure any cure. not just cfs or aids also saw many with ms looking into possible hope from ampligen you cant take away hope from the hopeless and not pay a hefty premium, from day 1 i said asenio blew it, he gave me the opportunity to load on heb in $5 range, heb and ampligen are different because ampligen seems to be working and there is no alternative cav